A recent study reported the growth promoting effect of FBXW5 in non-small cell lung cancer (NSCLC), via the degradation of Deleted in Liver Cancer (DLC1), a Rho GTPase-activating protein tumor suppressor [20]. Here, DLC1 is linked to non-small cell lung carcinoma.